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ABSTRACT
The clinical association of Wilms' tumour with aniridia, genitourinary
abnormalities and mental retardation (WAGR syndrome) is characterised cyto-
genetically by variable length, constitutional deletion of the short arm of
chromosome 11, which always includes at least part of band llpl3. HRAS1-
selected chromosome mediated gene transfer (CMGT) generated a transformant,
E65-6, in which the only human genes retained map either to band llpl3 or,
with HRAS1, in the region llpl5.4-pter. Human recombinants isolated from
E65-6 were mapped to a panel of five WAGR deletion hybrids and two clinically
related translocations. We show that E65-6 is enriched -400-fold for llpl5.4-
pter markers and -200-fold for llpl3 markers. 'Hitch-hiking' from HRAS1 with
CMGT markers has allowed us to define seven discrete intervals which subtend
band llpl3. Both associated translocations co-locate within the smallest
region of overlap for the WAGR locus, which has been redefined by identifying
a new interval closer than FSHB.
INTRODUCTION
In an earlier study (1), we described the establishment and cytogenetics
of lymphoblastoid cell lines derived from several WAGR patients, the segrega-
tion of deleted from normal chromosomes 11 in somatic cell hybrids and their
characterisation with defined gene markers. We showed that CAT and the cell
surface markers MIC4 and MICll all map to band llpl3 and are frequently but
not ubiquitously deleted in WAGR patients.
In a parallel study (2), we described the development of the chromosome
mediated gene transfer (CMGT) technique with selection for expression of the
activated HRAS1 oncogene, mapping at llp15.4-pter. This procedure facilitates
the stable isolation of human chromosome 11 fragments in mouse C127 cell3.
However, intrachromosomal rearrangement accompanies the CMGT process such that
markers centromere proximal to HRAS1 can be co-transferred while intervening
markers are lost.
Most recently (3), we described the isolation and sub-chromosomal locali-
sation of forty-four human DNA recombinants from one HRAS1-CMG trans-formant,
E67-1. This transformant contains =5OMbp of human DNA inserted interstitially
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at a single site on a mouse chromosome (4). Several chromosome 11 markers had
been co-transferred, including ones known to flank either side of the WAGR
locus (2). Mapping of the E67-1 derived recombinants to our panel of WAGR
deletions (now extended to five patients, three of which retain part of band
llpl3), together with two clinically associated llpl3 translocations, allowed
us to define ten discrete intervals on the short arm of chromosome 11 (3).
These included a centromere distal interval previously defined only by FSHB
(5,6) and a centromere proximal interval previously defined by CAT and MICll
(1,6). Thus, the CMGT approach rapidly generated a valuable and extensive set
of anonymous DNA markers for fine-structure mapping of the short arm of chro-
mosome 11. The enrichment for llpl3 markers was substantial and significantly
higher than would be expected from a chromosome 11 only hybrid or from a flow
sorted, chromosome 11 enriched library. However, although three new intervals
on the short arm of chromosome 11 were defined, none were closer to the WAGR
locus than the FSHB or the CAT/MICll intervals. The success of the clone
isolation and mapping exercise with E67-1 encouraged us to test other HRASI-
selected CMGT's, in particular those for which we had evidence for complex but
potentially adventitious intrachromosomal rearrangement.
The HRASl-selected CMG transformant E65-6 contains 10Mbp of human DNA
(2). Ll "fingerprinting" provides evidence for complex but stable amplifica-
tion and rearrangement of the isolated human DNA sequences (2). In situ
hybridisation analysis demonstrates the presence of three discrete blocks of
human chromatin, each carrying a copy of the HRAS1 oncogene (4,7). Of
particular relevance to the present study, only LDHA, FSHB and MICll, of all
the chromosome 11 genes tested, have been co-transferred along with HRAS1
(Table 1). Furthermore, several of the E67-1 derived recombinants which map
to band llpl3 cross-hybridise to E65-6 (Porteous et al., in prep.). E65-6
should therefore provide an ideal further test of the CMGT approach, not only
for isolating chromosomal segments which directly flank the selected locus
(8,9), but also for cloning syntenic sequences originally at a distance (CMGT
"hitch-hiking").
MATERIALS AND METHODS
Chromosome 11 somatic cell hybrids
The human-mouse cell hybrids lWl.LA4.9 and lB.8.1.6 retain chromosome 11
as their sole human component (1,6). We have tested over 150 gene specific
and anonymous DNA markers on chromosome 11 and all are present in lWlLA4.9,
whereas 1B.8.1.6 appears to have a terminal deletion of short arm material,
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Table 1. CHROMOSOME 11 GENES IN E65-6 AND WAGR RELATED HYBRIDS.
CELL UNE HRASI INS HBB PTH CALCI LDHA FSHB MICI I CAT MIC4 PGA CLG MICS APOAI
EJ-18-8D + + + + + + + + + + + + + +
IWI.LA4.9 + + + + + + + + + + + + + +
113.8.1.6. - + + + + + + + + + + + + +
E65-6 + . . - - + + + . . . .
NYX3.1 + + + + + + + + + +
GOX2 + + + + + + . . . . + + + +
SAX3.10 + + + + + + + + + + +
MAX15 + + + + + + + . . + + + + +
ANX3.10 + + + + + + . + + + + + + +
SMX13 + + + + + + + - - - - - - -
POR4I + + + + + + +
POR4
- - - - - - I - + + + + + + +
HRAS1, c-Harvey-ras-l; INS, insulin; HBB, a-globin; PTH, parathyroid hormone;
CALCl, calcitonin; LDHA, lactate dehydrogenase A; FSHB, follicle stimulating
hormone, a-subunit; CAT, catalase; PGA, pepsinogen A; CLG, collagenase;
APOAl, apolipoprotein Al; MICll, MIC4 and MIC8, cell surface markers recog-
nised respectively by monoclonals 163.A5, F10.44.2 and 4F10.
being negative for HRAS1 (Table 1) and tightly linked anonymous DNA markers.
The WAGR deletion hybrids NYX3.1, GOX2, ANX6.14, SAX3.10 and MAX15 have been
described in detail elsewhere (1,3,6). The deletions in NYX3.1 and GOX2 are
indistinguishable at the level of defined gene marker analysis (Table 1), but
cytogenetic analysis shows that the centromere distal break in GOX2 occurs in
band llpl4 whereas in NYX3.1 it extends to band llpl5.4 (1). Molecular
analysis with anonymous HRAS1-CMGT derived human recombinants confirms and
refines the cytogenetic interpretation (3). The deletions in ANX6.14, SAX10
and MAX15 are smaller and each retain part of band llpl3 (3,6). The recipro-
cal 2pll:llpl3 translocation hybrids POR4 and PORll were established from a
neonate with Potter facies and genitourinary dysplasia, with bilateral
undescended testes and urethral and uretral atresia, as described previously
(3,6). The SMX13 hybrid carries the llpl3-llpter portion of a reciprocal
translocation which segregates with aniridia in a Finnish family (10) and has
been described elsewhere (3,6). The LHV hybrids (5) are derived from the
same patient. E65-6 is one of a series of HRASl-selected chromosome mediated
gene (CMG) transformants, derived by transfection of mouse C127 cells with
mitotic chromosomes isolated from the human EJ bladder carcinoma cell line,
as described previously (2). Table 1 summarises the mapping data with respect
to defined genes for each of the hybrid cell lines.
Genomic library construction, probe isolation and mapping
Genomic library construction and screening, probe isolation and mapping
were essentially as described previously (3,11). Sau3A partial digest genomic
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libraries of E65-6 were constructed in the lambda cloning vector EMBL3 and
the cosmid cloning vector pJB8, using standard protocols. The libraries were
screened at moderate density with total human DNA as radiolabelled probe and
positive colonies or plaques counter-screened with radiolabelled total mouse
DNA. Cosmid DNA was prepared from liquid cultures using standard protocols.
Lambda DNA was prepared from cleared plate lysates using LambdaSorb (Promega
Biotec) which gave consistently good yields of nick-translatable DNA. Cosmid
and lambda human DNA recombinants were radiolabelled by nick translation to a
specific activity of =2xlO8cpm per pg. The repeated DNA element was removed
from the hybridisation reaction by pre-annealing with lOOpg unlabelled total
human DNA (3,11). The recombinants were mapped by hybridisation to panels of
WAGR deletion and translocation DNA's which had been digested with BamHI (5pg
per track), electrophoresed through 0.8% agarose and transferred to Hybond N
(Amersham Plc) membranes, according to the manufacturers instructions. Hybri-
disation was in 5xSSC, 5xDenhardt's, 0.5% SDS with 10/% dextran sulphate or
PEG 1500, at 68°C. Filters were washed to 0.1% x SSC in 0.1% SDS, 0.1%
sodium pyrophosphate at 68°C and exposed to autoradiographic film at -70°C
for 1-7 days.
RESULTS
19 cosmid and 35 lambda human DNA recombinants from E65-6 were localised
to chromosome 11, as illustrated in Figure 1. A majority of the E65-6
derived human DNA recombinants detect sequences which show varying degrees
of amplification and/or rearrangement in the E65-6 transformant compared with
the chromosome donor cell line, EJ-18-8D (Fig. la). This is consistent with
the prediction of rearrangement based on Ll 'fingerprinting' (2) and in situ
hybridisation analysis (4,7). It contrasts with only one genomic rearrange-
ment out of forty-four recombinants derived from the E67-1 transformant (3),
where the molecular and physical characterisation had suggested minimal
molecular scrambling (2,4,7).
Recombinants found to be deleted from NYX3.1, which encompasses all of
our remaining deletions (3), were further sub-localised by mapping to the
smaller WAGR deletion hybrids and the associated translocations, as illust-
rated in Figure 2 and summarised in Figure 3. None of the E65-6 derived
recombinants map below the centromere proximal breakpoint in NYX3.1.
CosE65-6-3 (see Fig. lb) and AE65-6-103 both map to the most distal deletion
region. AE65-6-1OA (corresponding to the higher mobility hybridising frag-
ment in Fig. 2b) maps one interval closer to the WAGR locus, in an interval
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Figure 1. Identification of WAGR deletion markers. E65-6 derived human
recombinants were hybridised to panels of chromosome 11 hybrid DNA's which
included the WAGR deletion hybrid NYX3.1. a) XE65-6-16; b) cosB65-6-3. See
the Materials and Methods section for details.
previously only defined by the E67-1 derived recombinant XP5B2.B (3).
All 11 remaining E65-6 derived WAGR deletion clones map to one or other
of 5 intervals which subtend band llpl3. CosE65-6-13, cosE65-6-22B and
XE65-6-128 map in the most centromere proximal deletion region, previously
defined only by the E67-1 derived recombinant cosE67-1-1 (3). CosE65-6-22A
and AE65-6-97 map to the same interval as the cell surface marker MIC4 (6)
and the E67-1 derived recombinant XP11F9 (3). CosE65-6-6, XE65-6-84 and
XE65-6-96 (see Fig. 2a) map immediately centromere proximal to the WAGR
locus, with the E67-1 markers XP2G4 and XP4Fll (3), in the MICll/CAT interval
(6). CosE65-6-8 maps to the centromere distal interval previously defined by
FSHB (5,6) and by the E67-1 marker XP12C9 (3). Finally and most importantly,
both XE65-6-74 and XE65-6-IOB (corresponding to the lower mobility hybridi-
sing fragment in Fig. 2b) map to a new interval, immediately centromere
distal to the SMX13 and the PORll translocation breakpoints, but centromere
proximal to XP12C9 and FSHB. These results refine and redefine the extent
of the smallest region of overlap for the WAGR locus.
It is of interest that XE65-6-10 hybridises to two discontinuous regions
on the short arm of chromosome 11 (Fig. 2b and Fig. 3). Further analysis will
be necessary to determine whether this is accountable by complex rearrangement
55
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Figure 2. Sub-localisation of WAGR deletion markers. Recombinants mapping
to the NYX3.1 deletion were sub-localised by hybridisation to an extended
panel of WAGR associated deletion and translocation hybrids, as described in
the Materials and Methods section. a) XE65-6-96; b) XE65-6-10.
within E65-6, bringing normally disparate DNA segments together, or whether
it truely reflects the existence of duplicated DNA segments on the short arm
of chromosome 11. The E67-1 derived recombinant XP5B2 positi-ely identifies
two distinct DNA segments which span the centromere distal breakpoint in G01.2
(3). A second E65-6 derived recombinant, cosE65-6-22, also hybridises to two
distinct regions of the chromosome 11 short arm (Figure 3).
DISCUSSION
The observation of chromosomal rearrangement accompanying the chromosome
transfer process prompts us to question the validity of this approach as a
first order mapping tool (12,13). However, the power of CMGT as an enrich-
ment cloning strategy for markers inrediately flanking the locus under
selection has been clearly demonstrated (8,9,13). Our results strongly
suggest that even those transgenomes which have undergone extensive and com-
plex rearrangement still consist largely, if not exclusively, of sequences
syntenic with the locus under selection. There is also a strong tendency for
markers tightly linked on the donor chromosome to co-segregate. All forty-
Lour of the recombinants derived from the HRAS1-CMG transformant E67-1 map to
chromosome 11 (3). All fifty-four of the E65-6 derived recombinants described
here, not only map to chromosome 11, but localise to predicted sub-regions on
the short arm.
Chromosome 11 is estimated to comprise =4.8% of the haploid genome,
equivalent to 14OMbp (14). It follows that E65-6 is enriched =200-fold
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Figure 3. A physical map of the short arm of chromosome 11 and the WAGR
region. The figure summarises the mapping of 19 cosmid and 35 lambda human
recombinants isolated from the HRASl-selected CMGT E65-6 to 5 independent WAGR
deletions and 2 WAGR associated translocations, as described in the text.
Asterisked clones show significant cross-hybridisation to mouse DNA at high
stringency and may therefore identify coding sequences.
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for band llpl3 markers and =400-fold for llp15.4-pter markers, on the reason-
able assumption that each region comprises =3.5% of the whole chromosome, or
~5M4bp. The CMGT approach therefore conpares favourably with other enrichment
cloning strategies, such as flow sorted chromosome libraries (15), microdis-
section of mitotic chromosome spreads (16) or subtractive hybridisation
protocols for deletion cloning (17). Success with the subtractive hybridisa-
tion strategy, moreover, has so far been restricted to the favourable condition
of hemizygous deletion of the X chromosome in males (17) and may not be fee-
sible for autosomal conditions. The idea of using CMGT associated intra-
chromosomal rearrangment to "hitch-hike" from the locus under selection to
distant but syntenic loci introduces an important new aspect to this cloning.
Indeed, as serendipitous intrachromosomal deletion appears to be a general
CMGT-associated phenomenon (2,3,13,18), the quest for a selectable marker
tightly linked to the chromosomal region of interest, while still the ideal,
should not limit the CMGT approach to enrichment cloning. With careful assess-
ment of syntenic marker co-transfer patterns, it may be possible to cover each
chromosome quite effectively using only a few selectable markers as "hitch-
hike" start points.
The discontinuous co-transfer of chromosome 11 markers in E67-1 in the
absence of significant molecular scrambling suggests a process of simple
intrachromosomal deletion and religation (3). The situation in E65-6 is more
complex. Hybridisation analysis with E65-6 derived human recombinants pro-
vides clear evidence for extensive rearrangement and local amplification
within the transgenome (Figure la). Understanding the nature and extent of
these CMGT associated chromosomal rearrangements is important to the overall
assessment and exploitation of the CMGT process. Long-range restriction
mapping by pulsed-field gel electrophoretic analysis (19) can address this
question and is in progress.
Our results add to the molecular definition of the WAGR locus. Mapping
of the E65-6 derived markers to the WAGR deletion and associated transloca-
tion hybrids defines seven discrete intervals which subtend band llpl3. Two
of the markers, XE65-6-IOB and XE65-6-74, map to a new interval which is
centromere distal to the aniridia (SMX) and the Potter facies (POR) associated
translocation breakpoints, but centromere proximal to FSHB. The smallest
region of overlap for the WAGR locus is redefined as lying between the centro--
mere proximal breakpoint in ANX6.14 and the centromere distal breakpoint in
SAX3.10. The close proximity of the Wilms' tumour (WT) and aniridia (AN2)
loci is confirmed and refined. Similarly, the physical location of the POR
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translocation breakpoint within the smallest region of overlap for WAGR is
maintained and, therefore, the possibility of a genetic relationship between
genitourinary dysplasia and Wilms' tumour is strengthened (3).
With the density of markers now achieved for this region, it should be
possible to construct a long-range restriction map of normal and WAGR associ-
ated chromosomes 11 by pulsed-field gel electrophoretic analysis (19) and thus
define precisely the molecular size of the SRO and the positions of the POR
and SMX translocation breakpoints. An even higher density of markers is
available for the llpl5.4 to llpter region. A precise physical map of this
region would permit comparison with the detailed genetic map already available
(20) aInd a direct route to disease genes mapping in this region (21).
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